{"url_path":"/sec/clrb/8-k/2026-05-08/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1279704/0001104659-26-057460-index.html","accession_number":"0001104659-26-057460","cik":"0001279704","ticker":"CLRB","issuer_name":"Cellectar Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1279704/0001104659-26-057460-index.html","primary_entity_key":"0001279704","primary_entity_name":"Cellectar Biosciences, Inc."},"word_count":67,"has_tables":true,"body_markdown":"**Item 3.02**\n**Unregistered Sales of Equity Securities.**\n\n \n\nThe Company issued the Unregistered\nShares, the Pre-Funded Warrants and the Milestone Warrants issued in the Private Placement pursuant to the exemption from the registration\nrequirements of the Securities Act of 1933, as amended (the “Securities Act”), available under Section 4(a)(2) and/or\nRule 506(b) of Regulation D promulgated thereunder. The description of the Pre-Funded Warrants and the Milestone Warrants under"}